Skip to content
Clinical Trials – home
Verifiedinfo

Assistance Publique Hopitaux De Marseille

France 265 Chemin Des Bourrely, 13015 Marseille, France

  • 300 trials recruiting
  • Non-small cell lung cancer · Neoplasm · Crohn's disease
  • Adults and children

About Specializations

Assistance Publique Hopitaux De Marseille in Marseille, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Neoplasm, Crohn's disease, Neoplasm malignant, and other specialisations. This site conducts important research.

Main research areas of the site

Periodontology and Oral Infection Research

At Assistance Publique Hopitaux De Marseille, clinical trials in parodontology focus on generalized periodontitis and related infectious disease questions. The studies are designed to assess whether adding a new antiviral approach can improve outcomes alongside standard periodontal care.

  • Evaluation of valaciclovir as a potential support to conventional non-surgical periodontal treatment
  • Assessment of treatment effectiveness for advanced periodontitis in adults
  • Research linking virus diseases and inflammatory conditions of the gums

This work aims to refine care for severe gum disease by comparing new therapeutic strategies with established dental treatment.

Digestive System Disease Studies

The site also conducts trials in digestive system diseases, with a strong emphasis on esophageal achalasia and reflux prevention after treatment. These studies explore ways to improve symptom control and reduce later complications in patients undergoing endoscopic care.

  • Prevention of gastroesophageal reflux after treatment for achalasia
  • Comparison of routine versus symptom-guided PPI use
  • Improving long-term digestive outcomes after POEM

The research is centered on testing better follow-up strategies and evaluating how to reduce reflux-related problems after intervention.

Hormonal Disease and Metabolic Care

Clinical research in hormonal diseases includes studies in type 2 diabetes, where investigators are examining whether changing therapy can lead to better blood sugar control. This reflects a practical focus on improving treatment effectiveness for patients already receiving diabetes care.

  • Comparison of two GLP-1-based treatments for glycemic control
  • Evaluation of treatment switching in adults with type 2 diabetes
  • Measurement of changes in HbA1c over time

The goal is to identify more effective options for managing diabetes in everyday clinical practice.

Skin and Connective Tissue Disease Research

Trials in skin and connective tissue diseases at this hospital site intersect with inflammatory and tissue-related conditions that affect the mouth and surrounding structures. The research supports a broader effort to understand how chronic inflammation responds to different treatment approaches.

  • Study of inflammatory tissue changes associated with periodontal disease
  • Testing strategies that may improve healing in chronic connective tissue conditions
  • Clinical evaluation of therapies aimed at reducing persistent inflammation

These studies are intended to strengthen knowledge of how chronic tissue disorders can be managed more effectively.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
265 Chemin Des Bourrely13015 MarseilleFrance
Recruiting now
300 trials
Conditions studied
241
Partner status
Verified

More sites in MarseilleFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

936 clinical trials

Asthma

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anifrolumab
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Indacaterol Acetate
  • Sponsor:Novartis Pharma AG
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Sponsor:Ferrer Internacional S.A.
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Empasiprubart
  • Sponsor:Argenx
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:NAVENIBART
  • Sponsor:Astria Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Exelixis Inc.
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).